SCHEMBL1635580

SCHEMBL1635580

O=C(O)C(=O)CC(=O)[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO

nearest known ligand 0.59

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.59
PDE4A P27815 1/20 0.57
L3MBTL1 Q9Y468 1/20 0.44
USP2 O75604 1/20 0.44
SLCO1B1 Q9Y6L6 1/20 0.44
TDP1 Q9NUW8 1/20 0.42
KDM4E B2RXH2 2/20 0.38
CYP2C9 P11712 1/20 0.38
TSHR P16473 1/20 0.38
OR51E2 Q9H255 2/20 0.32
SMN1; SMN2 Q16637 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7132995 0.83 PDE4A (0.61) LMNAPDE4AL3MBTL1USP2SLCO1B1
SCHEMBL378867 0.83 PDE4A (0.61) LMNAPDE4AL3MBTL1USP2SLCO1B1
SCHEMBL28066668 0.83 PDE4A (0.61) LMNAPDE4AL3MBTL1USP2SLCO1B1
SCHEMBL6234202 0.82 PDE4A (0.59) LMNAPDE4AL3MBTL1USP2SLCO1B1
SCHEMBL9576619 0.82 PDE4A (0.59) LMNAPDE4AL3MBTL1USP2SLCO1B1
SCHEMBL6234198 0.80 LMNA (0.64) LMNAPDE4AL3MBTL1USP2SLCO1B1
Gluconic Acid SCHEMBL27491398 0.79 LMNA (0.91) LMNAPDE4AL3MBTL1USP2SLCO1B1
Gluconic Acid SCHEMBL29416831 0.79 LMNA (0.91) LMNAPDE4AL3MBTL1USP2SLCO1B1
Gluconic Acid SCHEMBL537856 0.79 LMNA (0.91) LMNAPDE4AL3MBTL1USP2SLCO1B1
Gluconic Acid SCHEMBL27663242 0.78 PDE4A (0.66) LMNAPDE4AL3MBTL1USP2SLCO1B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 220 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024003178-A1 Composition comprising a peroxygenated salt, an associative polymer, a non-associative polysaccharide and a hydrocarbon with a melting point greater than 25°C L'OREAL (FR) 2024-01-04 WO claimed
EP-4262996-A1 COSMETIC COMPOSITION COMPRISING AN AMINO SILICONE, A NON-AMINO SILICONE AND A NON-IONIC ASSOCIATIVE POLYMER, AND COSMETIC TREATMENT PROCESS L'OREAL (FR) 2023-10-25 EP claimed
CN-116367818-A Cosmetic composition comprising an aminosilicone, a non-aminosilicone, and a nonionic associative polymer and cosmetic treatment method 莱雅公司 2023-06-30 CN claimed
WO-2022135924-A1 COSMETIC COMPOSITION COMPRISING AN AMINO SILICONE, A NON-AMINO SILICONE, AN ASSOCIATIVE POLYMER AND A NON-ASSOCIATIVE POLYSACCHARIDE; AND COSMETIC TREATMENT PROCESS L'OREAL (FR) 2022-06-30 WO claimed
WO-2022135927-A1 COSMETIC COMPOSITION COMPRISING AN AMINO SILICONE, A NON-AMINO SILICONE AND A NON-IONIC ASSOCIATIVE POLYMER, AND COSMETIC TREATMENT PROCESS L'OREAL (FR) 2022-06-30 WO claimed
EP-3233203-B1 DYEING PROCESS STARTING FROM ORTHO-DIPHENOL OREAL (FR) 2021-11-24 EP claimed
US-20170326048-A1 DYEING PROCESS STARTING FROM ORTHO-DIPHENOL L'OREAL (FR) 2017-11-16 US claimed
EP-3233203-A1 DYEING PROCESS STARTING FROM ORTHO-DIPHENOL L'OREAL (FR) 2017-10-25 EP claimed
WO-2016097246-A1 DYEING PROCESS STARTING FROM ORTHO-DIPHENOL L'OREAL (FR) 2016-06-23 WO claimed
WO-2024126541-A1 COSMETIC COMPOSITION COMPRISING PIROCTONE OLAMINE, AT LEAST 1% NIACINAMIDE AND A GINGER ROOT EXTRACT L'OREAL (FR) 2024-06-20 WO disclosed
WO-2024126539-A1 COSMETIC COMPOSITION COMPRISING 2,4-DIAMINOPYRIMIDINE 3-N-OXIDE, PIROCTONE OLAMINE, NIACINAMIDE, AND AT LEAST 1 % BY WEIGHT OF PARTICULAR HYDROXYLATED COMPOUND L'OREAL (FR) 2024-06-20 WO disclosed
CN-118043027-A Process for dyeing and/or lightening keratin fibres 莱雅公司 2024-05-14 CN disclosed
EP-4362901-A1 COMPOSITION COMPRISING AT LEAST ONE PARTICULAR OXIDATION DYE, AT LEAST ONE SHEA-DERIVED FATTY SUBSTANCE AND AT LEAST ONE ALKALINE AGENT L'OREAL (FR) 2024-05-08 EP disclosed
EP-4362890-A1 COMPOSITION COMPRISING AT LEAST ONE OXIDATION DYE, AT LEAST ONE ALKALINE AGENT AND AT LEAST ONE LIQUID FATTY ALCOHOL AND AT LEAST ONE SOLID FATTY ALCOHOL L'OREAL (FR) 2024-05-08 EP disclosed
US-20120103358-A1 CAPILLARY COMPOSITION FOR TREATING HAIR L'OREAL (FR) 2012-05-03 US disclosed
US-20120093900-A1 CAPILLARY COMPOSITION FOR TREATING HAIR L'OREAL (FR) 2012-04-19 US disclosed
US-20110171153-A1 TREATMENT OF KERATIN FIBRES WITH VOLATILE LINEAR ALKANE(S), SOLID FATTY ALCOHOL(S) AND POLYMERIC THICKENER(S) CONTAINING SUGAR UNITS L'OREAL (FR) 2011-07-14 US disclosed
US-7931698-B2 Ready-to-use composition for oxidation dyeing of keratin fibers comprising at least one fatty substance, at least one thickener, at least one dye precursor, at least one oxidizing agent, and at least one alkaline agent, and process and kits therewith L'OREAL S.A. (FR) 2011-04-26 US disclosed
WO-2010133573-A2 DYEING COMPOSITION COMPRISING A SECONDARY PARA-PHENYLENEDIAMINE OXIDATION BASE AND A THICKENING POLYMER L'OREAL (FR) 2010-11-25 WO disclosed
US-20100154140-A1 READY-TO-USE COMPOSITION FOR OXIDATION DYEING OF KERATIN FIBERS COMPRISING AT LEAST ONE FATTY SUBSTANCE, AT LEAST ONE THICKENER, AT LEAST ONE DYE PRECURSOR, AT LEAST ONE OXIDIZING AGENT, AND AT LEAST ONE ALKALINE AGENT, AND PROCESS AND KITS THEREWITH L'OREAL S.A. (FR) 2010-06-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100154140-A1 READY-TO-USE COMPOSITION FOR OXIDATION DYEING OF KERATIN FIBERS COMPRISING AT LEAST ONE FATTY SUBSTANCE, AT LEAST ONE THICKENER, AT LEAST ONE DYE PRECURSOR, AT LEAST ONE OXIDIZING AGENT, AND AT LEAST ONE ALKALINE AGENT, AND PROCESS AND KITS THEREWITH KRT18, OAT, CKMT1A; CKMT1B LMNA 420/4885PDE4A 3188/4885L3MBTL1 4806/4885
US-20120093900-A1 CAPILLARY COMPOSITION FOR TREATING HAIR POLE3, POLR1C, NUP205 LMNA 2731/4885PDE4A 2334/4885L3MBTL1 3797/4885
US-20110171153-A1 TREATMENT OF KERATIN FIBRES WITH VOLATILE LINEAR ALKANE(S), SOLID FATTY ALCOHOL(S) AND POLYMERIC THICKENER(S) CONTAINING SUGAR UNITS KRT18, DSG1, FASN LMNA 1524/4885PDE4A 4478/4885L3MBTL1 4073/4885
US-20170326048-A1 DYEING PROCESS STARTING FROM ORTHO-DIPHENOL DSG1, KRT18, DSP LMNA 1484/4885PDE4A 4423/4885L3MBTL1 4834/4885
US-20120103358-A1 CAPILLARY COMPOSITION FOR TREATING HAIR POLE3, POLR1C, PUM1 LMNA 1861/4885PDE4A 1974/4885L3MBTL1 3399/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.